Sciences

(Reuters) - The US Food and Drug Administration imposed a clinical suspension on the drug Kezar Life Sciences (NASDAQ:)' trial of an experimental drug for lupus, the company said Friday. The FDA's decision comes after the company…

Cassava ScienceNASDAQ:SAVAGeneral Electric Automotive Co. announced changes to its executive leadership on Wednesday, with Richard Barry taking over as the company's chief executive officer and executive chairman of the board. The…

On Monday, Raymond James changed its stance on Gilead Sciences Inc. (NASDAQ:GIL) stock, upgrading it from “market perform” to “outperform.” The firm also set a $93.00 price target for the biopharmaceutical company. This update is bolstered…

US biopharmaceutical giant Gilead Sciences Inc. (Nasdaq: GILD) today announced an agreement with Israeli clinical-stage cancer immunotherapy company Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), which uses computational…